Merck (MRK) Over-Hyped in Hep C, Says Wells Fargo (GILD) (ABBV)
Go back to Merck (MRK) Over-Hyped in Hep C, Says Wells Fargo (GILD) (ABBV)| AbbVie (NYSE: ABBV) | Delayed: 256.46 -3.75 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $260.21 | 52 Week High | $68.12 | |||
| Open | $257.96 | 52 Week Low | $50.71 | |||
| Day High | $258.91 | P/E | 55.63 | |||
| Day Low | $255.58 | EPS | $4.61 | |||
| Volume | 4,729,357 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 151.00 -0.22 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $151.22 | 52 Week High | $108.63 | |||
| Open | $149.23 | 52 Week Low | $71.39 | |||
| Day High | $151.19 | P/E | 83.43 | |||
| Day Low | $149.23 | EPS | $1.81 | |||
| Volume | 6,181,391 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 150.33 -2.01 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.34 | 52 Week High | $65.46 | |||
| Open | $150.83 | 52 Week Low | $47.97 | |||
| Day High | $152.22 | P/E | 102.27 | |||
| Day Low | $150.09 | EPS | $1.47 | |||
| Volume | 4,395,788 | |||||
